T5
Last reporting period 30 Jun, 2021
Updated 19 Sep, 2024
Last price
—
Market cap $B
0
Exchange
XETR - Xetra
-0.0006 B
Last period FCFE ,EUR
-40%
FCFE has decreased in 5 years
What is FCFE ?
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
See also bioXXmed
Company Analysis
T5O.DE valuation, rating, competitors, insights and company profile
Eyestock Rating
T5O.DE financial analysis by Eyestock methodology
Valuation
T5O.DE valuation using historical relative method
Statements
T5O.DE Income Statements, Balance Sheet and Cash Flow Statements
Dividends
T5O.DE dividend yield and annual dividend
Free cash flow is the amount of cash a company has after all operating expenses, interest and taxes, and capital expenditures have been paid.
bioXXmed`s FCFE for the period ended 2021-06-30 is -0.0006 B EUR
